UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006478 |
|---|---|
| Receipt number | R000007690 |
| Scientific Title | Multicenter Phese II Study of Optimal-XELOX plus Bevacizumab Therapy with Oxaliplatin Stop-and-Go Strategy and Oral capecitabin plus Bevacizumab Maintenance Therapy in Advanced Colorectal Cancer |
| Date of disclosure of the study information | 2011/10/05 |
| Last modified on | 2016/11/16 08:54:45 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/10/05 13:04:38 | ||
| 2 | Update | 2011/12/01 18:56:02 | Recruitment status |
|
| 3 | Update | 2014/10/12 19:27:51 | TEL |
|
| 4 | Update | 2016/06/22 11:18:24 | Name of primary person or sponsor Organization |
|
| 5 | Update | 2016/06/22 11:21:24 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results |
|
| 6 | Update | 2016/11/16 08:37:01 | Key inclusion criteria |
|
| 7 | Update | 2016/11/16 08:54:45 | Recruitment status |
